Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiasp vs NovoLog Correction Bolus in T1DM (PLATEAU)
NCT04414579Phase 4Unknown
- Sponsor
- Mountain Diabetes and Endocrine Center
- Start
- Mar 2019
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of faster-acting insulin aspart in type 1 diabetes mellitus (T1D), sponsored by Mountain Diabetes and Endocrine Center. Status: unknown.
02
Drugs
faster-acting insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04414579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414579.